Medical therapy for benign prostatic hyperplasia.
نویسندگان
چکیده
منابع مشابه
Pathology and Medical Therapy of Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia (BPH) is a progressive condition characterised by prostate enlargement accompanied by lower urinary tract symptoms (LUTS). It contributes to, but is not the sole cause of LUTS. It is well known that BPH and the resultant LUTS is very common in elderly men and has a great impact on the patients’ quality of life. It was estimated that in the male population, a histolo...
متن کاملMedical management of benign prostatic hyperplasia.
The management of benign prostatic hyperplasia has undergone a rapid evolution over the past decade from a surgical emphasis to a medical emphasis. Great strides in the development of alpha-adrenergic blockers, 5 alpha-reductase inhibitors and a variety of phytotherapeutics have fueled this evolution. This article reviews the past, present and future of the medical management of benign prostati...
متن کاملPhytotherapy for benign prostatic hyperplasia.
OBJECTIVE To systematically review the existing evidence regarding the efficacy and safety of phytotherapeutic compounds used to treat men with symptomatic benign prostatic hyperplasia (BPH). DESIGN Randomized trials were identified searching MEDLINE (1966--1997), EMBASE, Phytodok, the Cochrane Library, bibliographies of identified trials and review articles, and contact with relevant authors...
متن کاملBenign prostatic hyperplasia.
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic rec...
متن کاملBenign Prostatic Hyperplasia
Urinary obstruction as a result of benign prostatic disease has probably been recognized to some degree since the earl iest days of medicine. This association was probably f irst formalized by Riolan in the seventeenth century. In the mideighteenth century, Morgagni (248) provided one of the earl iest descriptions of BPH and enumerated many of the potential medical problems attendant to its dev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Roentgenology
سال: 1995
ISSN: 0361-803X,1546-3141
DOI: 10.2214/ajr.164.1.7527995